Advertisement
tonsillitis

Leukemic Tonsillitis Presenting as Sore Throat

MICHAEL A. THOMPSON, MD, PhD and STEFAN FADERL, MD
University of Texas, M. D. Anderson Cancer Center

At the time this case report was written, Dr Thompson and Dr Faderl were at the University of Texas, M. D. Anderson Cancer Center in Houston.

Many patients with hematologic malignancies are initially seen in the primary care setting. Here we demonstrate such a case in a young woman who presented with a sore throat. She was referred to a tertiary care center because of abnormal blood cell counts and was then rapidly treated with resolution of symptoms.

THE CASE

A previously healthy 21-year-old woman presented with a sore throat of a few weeks’ duration. Her primary care provider prescribed an antibiotic; however, the symptoms did not resolve. A complete blood cell count was ordered, which revealed a significantly elevated white blood cell count (WBC) of 78,000/µL. She was hospitalized for further evaluation.

Leukemic Tonsillitis, sore throat

Physical examination results were unremarkable except for 1-cm postauricular and anterior and posterior cervical lymph nodes. The throat showed bilaterally enlarged tonsils without exudates and no evidence of mucositis (Figure 1).

A throat culture was negative for streptococci and other bacteria. The WBC count revealed 91% blasts with Auer rods. Other laboratory results included hemoglobin, 11.4 g/dL; platelets, 65,000/µL; and lactate dehydrogenase, 1281 IU/L (upper limit of normal, 618 IU/L).

She was started on hydroxyurea 3 g/d and allopurinol 300 mg/d until further evaluation revealed acute myeloid leukemia without maturation (AML M1) with inversion (16) cytogenetics. Within a few hours after admission, the patient reported enlargement in the size of her tonsils, which was associated with difficulty in speaking. She was treated with 1 g cytarabine followed by the FLAG (fludarabine, cytarabine, granulocyte colony-stimulating factor) induction regimen—fludarabine 30 mg/m2/d for
5 days and cytarabine 2 g/m2/d for 5 days.

She had an immediate improvement in throat symptoms, and at 3 weeks she had resolution of her enlarged tonsils (Figure 2), reduction of marrow blasts to 5% or less, and blood recovery. She was then treated with 6 further consolidation courses. The patient is now in a continuous complete response at 9 months.

Leukemic Tonsillitis, sore throat

DISCUSSION

Sore throat is a common presenting symptom in primary care practice. Lymph node or tonsil enlargement can also occur as a direct involvement of extramedullary tissues with leukemic blasts. Treatment with chemotherapy can lead to rapid resolution of symptoms.